NASDAQ · ATRC
AtriCure, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ATRC: Nov 03, 2026
AtriCure, Inc. Common Stock is expected to report earnings on 11/03/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $0.01. The reported EPS for the same quarter last year was $-0.01.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.01 | $0.01 | $0.01 | 2 |
| Dec 2026 | $0.10 | $0.11 | $0.09 | 2 |
| Mar 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Jun 2027 | $0.15 | $0.15 | $0.15 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · The Motley Fool · MarketBeat- RTTNews · Sep 24, 5:26 AM EDTBiotech Stocks At 52-Week Highs – TKNO, MRNA, ATRC, ILMN(RTTNews) – The following biotech stocks reached a 52-week high on September 23, 2026, driven by key catalysts such as positive quarterly reports or results from clinical trials.
- RTTNews · Sep 15, 3:25 AM EDTBiotech Stocks At 52-Week Highs – NUTX +8%, IOVA +7%, ATRC, CNC, CON(RTTNews) – The following biotech stocks reached a 52-week high on September 15, 2026, driven by the gain on certain clinical or financial results.
- Zacks · Sep 14, 9:40 AM EDTIs AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
- The Motley Fool · Sep 12, 8:05 PM EDTAtriCure CTO Sells 3,657 SharesThe transaction was valued at $201,000.
- Zacks · Sep 10, 10:39 AM EDTDo Options Traders Know Something About AtriCure Stock We Don't?Investors need to pay close attention to ATRC stock based on the movements in the options market lately.
- Zacks · Sep 9, 3:53 PM EDTAtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue?AtriCure (ATRC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- RTTNews · Sep 9, 3:06 AM EDTBiotech Stocks At 52-Week Highs – PHVS +7%, ROIV +6% On Trial Readouts, BLSM +4%, ATRC, FTH(RTTNews) – The following biotech stocks reached a 52-week high on September 8, 2026, driven by a series of clinical developments and important regulatory milestones. Pharvaris N.V. (PHVS) Pharvaris is a late-stage biopharmaceutical company developing oral bradykinin B2 recep
- RTTNews · Sep 4, 5:15 AM EDTBiotech Stocks At 52-Week Highs – ATTO, HALO, IKT, TVTX, ATRC(RTTNews) – The following biotech stocks reached a 52-week high on September 3, 2026, as various clinical trials reported financial results and reached certain regulatory milestones.
- RTTNews · Aug 31, 5:01 AM EDTBiotech Stocks At 52-Week Highs – RNXT +12%, BLSM, RVTY, ATRC, BFRI(RTTNews) – The following biotech stocks reached a 52-week high on August 28, 2026, as various clinical trials reported initial data and companies reached certain regulatory milestones.
- Zacks · Aug 27, 9:40 AM EDTIs AtriCure (ATRC) Outperforming Other Medical Stocks This Year?Here is how AtriCure (ATRC) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
- RTTNews · Aug 19, 4:21 AM EDTBiotech Stocks At 52-Week Highs – AMLX +63% With Phase 3 Data, VOGX +25%, OBIO +19%, ATRC, CRL(RTTNews) – The following biotech stocks reached a 52-week high on August 18, 2026, primarily driven by positive quarterly reports.
- MarketBeat · Aug 11, 10:04 PM EDTAtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel GrowthAtriCure (NASDAQ:ATRC) said it is seeing continued growth across its atrial fibrillation, left atrial appendage management and postsurgical pain-management businesses, supported by new product adoption, expanding procedure volumes and progress in clinical trials. Speaking at the
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for AtriCure, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.